Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNAI3 | P08754 | 2/20 | 0.33 |
| ▸ | GNAO1 | P09471 | 2/20 | 0.33 |
| ▸ | GNAI1 | P63096 | 2/20 | 0.33 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.32 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.32 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | DRD2 | P14416 | 1/20 | 0.30 |
| ▸ | DRD3 | P35462 | 1/20 | 0.30 |
| ▸ | GBA1 | P04062 | 3/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12910969 | 0.94 | ALDH1A1 (0.31) | GNAI3GNAO1GNAI1 | |
| SCHEMBL893039 | 0.93 | GNAI3 (0.37) | GNAI3GNAO1GNAI1S1PR4S1PR1 | |
| SCHEMBL870983 | 0.90 | GNAI3 (0.38) | GNAI3GNAO1GNAI1S1PR4S1PR1 | |
| SCHEMBL2369217 | 0.88 | GNAI3 (0.34) | GNAI3GNAO1GNAI1S1PR4S1PR1 | |
| SCHEMBL8532351 | 0.87 | GNAI3 (0.41) | GNAI3GNAO1GNAI1S1PR4S1PR1 | |
| SCHEMBL9491106 | 0.87 | GNAI3 (0.41) | GNAI3GNAO1GNAI1S1PR4S1PR1 | |
| SCHEMBL26668878 | 0.87 | GNAI3 (0.41) | GNAI3GNAO1GNAI1S1PR4S1PR1 | |
| SCHEMBL27486181 | 0.86 | SQLE (0.35) | GNAI3GNAO1GNAI1S1PR4S1PR1 | |
| SCHEMBL18872779 | 0.86 | — | — | |
| SCHEMBL2369632 | 0.85 | GNAI3 (0.34) | GNAI3GNAO1GNAI1S1PR4S1PR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 91 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4457069-A1 | POLYMER COMPOSITIONS HAVING DENSIFICATION ACCELERATORS AND ROTATIONAL MOLDING PROCESSES FOR MAKING HOLLOW ARTICLES THEREFROM | Cytec Industries Inc. (US) | 2024-11-06 | — | — | EP | disclosed |
| EP-4363506-A1 | COMPOSITIONS AND METHODS FOR PROTECTING COATINGS FROM THE DELETERIOUS EFFECTS OF EXPOSURE TO UV-C LIGHT | Cytec Industries Inc. (US) | 2024-05-08 | — | — | EP | disclosed |
| EP-4341341-A1 | STABILIZED POLYMER RESIN SYSTEMS HAVING HETEROPOLYOXOMETALATES FOR ANTIMICROBIAL PROPERTIES AND USES THEREOF | SPECIALTY OPERATIONS FRANCE (FR) | 2024-03-27 | — | — | EP | disclosed |
| EP-4251689-A1 | COMPOSITIONS AND METHODS FOR PROTECTING ORGANIC POLYMERIC MATERIALS FROM DISCOLORATION DUE TO EXPOSURE TO UV-C LIGHT | Cytec Industries, Inc. (US) | 2023-10-04 | — | — | EP | disclosed |
| WO-2023129464-A1 | POLYMER COMPOSITIONS HAVING DENSIFICATION ACCELERATORS AND ROTATIONAL MOLDING PROCESSES FOR MAKING HOLLOW ARTICLES THEREFROM | CYTEC INDUSTRIES INC. (US) | 2023-07-06 | — | — | WO | disclosed |
| WO-2023278282-A1 | COMPOSITIONS AND METHODS FOR PROTECTING COATINGS FROM THE DELETERIOUS EFFECTS OF EXPOSURE TO UV-C LIGHT | CYTEC INDUSTRIES INC. (US) | 2023-01-05 | — | — | WO | disclosed |
| WO-2022243306-A1 | STABILIZED POLYMER RESIN SYSTEMS HAVING HETEROPOLYOXOMETALATES FOR ANTIMICROBIAL PROPERTIES AND USES THEREOF | RHODIA OPERATIONS (FR) | 2022-11-24 | — | — | WO | disclosed |
| WO-2022115573-A1 | COMPOSITIONS AND METHODS FOR PROTECTING ORGANIC POLYMERIC MATERIALS FROM DISCOLORATION DUE TO EXPOSURE TO UV-C LIGHT | CYTEC INDUSTRIES INC. (US) | 2022-06-02 | — | — | WO | disclosed |
| CN-105693698-B | Multi-functional hindered amine light stabilizer | 巴斯夫欧洲公司 | 2019-11-22 | — | — | CN | disclosed |
| US-9963575-B2 | Sterically hindered amine light stabilizers with a mixed functionalization | BASF SE (DE) | 2018-05-08 | — | — | US | disclosed |
| EP-2035382-A1 | PROCESS FOR THE PREPARATION OF STERICALLY HINDERED NITROXYL ETHERS | Ciba Holding Inc. (CH) | 2009-03-18 | — | — | EP | disclosed |
| US-20090069470-A1 | Process for the synthesis of n-alkoxyamines | CIBA SPECIALTY CHEMICALS CORP. | 2009-03-12 | — | — | US | disclosed |
| US-20090069470-A1 | Process for the synthesis of n-alkoxyamines | CIBA SPECIALTY CHEMICALS CORP. | 2009-03-12 | — | — | US | disclosed |
| WO-2008003602-A1 | PROCESS FOR THE PREPARATION OF STERICALLY HINDERED NITROXYL ETHERS | CIBA HOLDING INC. (CH) | 2008-01-10 | — | — | WO | disclosed |
| WO-2008003605-A1 | PROCESS FOR THE PREPARATION OF STERICALLY HINDERED NITROXYL ETHERS | CIBA HOLDING INC. (CH) | 2008-01-10 | — | — | WO | disclosed |
| WO-2008003605-A1 | PROCESS FOR THE PREPARATION OF STERICALLY HINDERED NITROXYL ETHERS | CIBA HOLDING INC. (CH) | 2008-01-10 | — | — | WO | disclosed |
| US-6677451-B2 | POLYMER STABILIZERS; OXYGEN, HEAT, RADIATION RESISTANCES; DISCOLORATION INHIBITION; COATINGS; FIBERS; TAPES; FILMS; PAPERMAKING; HALS; FIREPROOFING; OXIDATION OF A 1-ALLYL-SUBSTITUTED STERICALLY HINDERED AMINE | CIBA SPECIALTY CHEMICALS CORPORATION | 2004-01-13 | — | — | US | disclosed |
| US-20020094976-A1 | Preparation of sterically hindered amine ethers | ZEDDA ALESSANDRO (IT) | 2002-07-18 | — | — | US | disclosed |
| US-6420462-B1 | OXIDATION RESISTANCE, HEAT RESISTANT AND ACTINIC DEGRADATIONHETEROCYCLIC AMINE OXIDES | CIBA SPECIALTY CHEMICALS CORPORATION | 2002-07-16 | — | — | US | disclosed |
| US-6117995-A | OXIDATION OF THE CORRESPONDING HETEROCYCLIC AMINE COMPOUND | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2000-09-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090069470-A1 | Process for the synthesis of n-alkoxyamines | PNMT, PAOX, PAH | GNAI3 3443/4885GNAO1 1607/4885GNAI1 3280/4885 |
| US-20020094976-A1 | Preparation of sterically hindered amine ethers | CBR1, CBR3, RER1 | GNAI3 3318/4885GNAO1 2176/4885GNAI1 3179/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.